EBITDA Summary of SciVision Biotech Inc.

SciVision Biotech Inc.'s latest annual EBITDA in 2023 was 281.34 Million TWD , up 18.07% from previous year.
SciVision Biotech Inc.'s latest quarterly EBITDA in 2024 Q2 was 81.11 Million TWD , up 12.53% from previous quarter.
SciVision Biotech Inc. reported an annual EBITDA of 238.28 Million TWD in 2022, up 34.42% from previous year.
SciVision Biotech Inc. reported an annual EBITDA of 177.27 Million TWD in 2021, up 0.04% from previous year.
SciVision Biotech Inc. reported a quarterly EBITDA of 81.11 Million TWD for 2024 Q2, up 12.53% from previous quarter.
SciVision Biotech Inc. reported a quarterly EBITDA of 59.77 Million TWD for 2023 Q1, up 9.99% from previous quarter.

Annual EBITDA Chart of SciVision Biotech Inc. (2023 - 2009)

Historical Annual EBITDA of SciVision Biotech Inc. (2023 - 2009)

Year	EBITDA	EBITDA Growth
2023	281.34 Million TWD	18.07%
2022	238.28 Million TWD	34.42%
2021	177.27 Million TWD	0.04%
2020	177.2 Million TWD	14.19%
2019	155.18 Million TWD	33.3%
2018	116.41 Million TWD	143.56%
2017	47.79 Million TWD	1103.74%
2016	-4.76 Million TWD	-107.12%
2015	66.85 Million TWD	2335.79%
2014	-2.99 Million TWD	-105.53%
2013	54.1 Million TWD	-25.06%
2012	73.24 Million TWD	9.6%
2011	66.43 Million TWD	661.16%
2010	8.65 Million TWD	127.46%
2009	-31.21 Million TWD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	82.59 Million TWD	23.21%
2024 Q2	81.11 Million TWD	12.53%
2023 Q1	59.77 Million TWD	9.99%
2023 FY	- TWD	18.07%
2023 Q4	67.03 Million TWD	-25.63%
2023 Q3	90.13 Million TWD	39.98%
2023 Q2	64.39 Million TWD	7.72%
2022 FY	- TWD	34.42%
2022 Q4	54.35 Million TWD	-22.51%
2022 Q3	70.13 Million TWD	-2.48%
2022 Q2	71.92 Million TWD	71.75%
2022 Q1	41.87 Million TWD	-16.43%
2021 FY	- TWD	0.04%
2021 Q1	36.46 Million TWD	-26.76%
2021 Q2	46.98 Million TWD	28.83%
2021 Q3	43.71 Million TWD	-6.95%
2021 Q4	50.1 Million TWD	14.61%
2020 FY	- TWD	14.19%
2020 Q1	46.34 Million TWD	-9.9%
2020 Q2	33.04 Million TWD	-28.69%
2020 Q3	46.32 Million TWD	40.19%
2020 Q4	49.79 Million TWD	7.49%
2019 Q2	36.06 Million TWD	5.34%
2019 FY	- TWD	33.3%
2019 Q4	51.43 Million TWD	53.74%
2019 Q3	33.45 Million TWD	-7.22%
2019 Q1	34.23 Million TWD	-9.66%
2018 Q2	10.8 Million TWD	-75.68%
2018 FY	- TWD	143.56%
2018 Q3	23.45 Million TWD	117.04%
2018 Q4	37.89 Million TWD	61.58%
2018 Q1	44.43 Million TWD	51.46%
2017 Q3	7.11 Million TWD	-2.06%
2017 FY	- TWD	1103.74%
2017 Q2	7.26 Million TWD	77.86%
2017 Q1	4.08 Million TWD	-83.02%
2017 Q4	29.33 Million TWD	312.37%
2016 Q2	7.42 Million TWD	54.81%
2016 Q3	-41.02 Million TWD	-652.71%
2016 Q4	24.04 Million TWD	158.61%
2016 FY	- TWD	-107.12%
2016 Q1	4.79 Million TWD	-38.12%
2015 Q2	11.52 Million TWD	-37.9%
2015 Q4	7.74 Million TWD	-74.44%
2015 FY	- TWD	2335.79%
2015 Q1	18.55 Million TWD	204.15%
2015 Q3	30.31 Million TWD	163.09%
2014 Q2	5.47 Million TWD	199.95%
2014 FY	- TWD	-105.53%
2014 Q4	-17.81 Million TWD	-641.71%
2014 Q3	3.28 Million TWD	-39.95%
2014 Q1	1.82 Million TWD	-84.07%
2013 Q2	12.97 Million TWD	1.79%
2013 Q4	11.46 Million TWD	-32.28%
2013 FY	- TWD	-25.06%
2013 Q1	12.74 Million TWD	-59.86%
2013 Q3	16.92 Million TWD	30.5%
2012 Q4	31.74 Million TWD	70.69%
2012 Q3	18.59 Million TWD	39.7%
2012 Q1	9.3 Million TWD	-48.38%
2012 Q2	13.31 Million TWD	43.12%
2012 FY	- TWD	9.6%
2011 Q3	17.83 Million TWD	0.0%
2011 FY	- TWD	661.16%
2011 Q4	18.02 Million TWD	1.04%
2011 Q2	- TWD	0.0%
2010 FY	- TWD	127.46%
2010 Q4	- TWD	0.0%
2009 FY	- TWD	0.0%

Peer EBITDA Comparison of SciVision Biotech Inc.

Name	EBITDA	EBITDA Difference
Nang Kuang Pharmaceutical Co., Ltd.	402.69 Million TWD	30.134%
Maxigen Biotech Inc.	177.09 Million TWD	-58.87%
Bionime Corporation	179.78 Million TWD	-56.495%
Pegavision Corporation	2.91 Billion TWD	90.358%
Visco Vision Inc.	733.58 Million TWD	61.648%

Global Stocks Search

SciVision Biotech Inc. (1786.TW)

EBITDA Summary of SciVision Biotech Inc.

Annual EBITDA Chart of SciVision Biotech Inc. (2023 - 2009)

Historical Annual EBITDA of SciVision Biotech Inc. (2023 - 2009)

Peer EBITDA Comparison of SciVision Biotech Inc.